Skip to main content
Log in

Experimental study on interleukin 6 activity against tumor; Regulation of interleukin-2 induced lak cell activity

  • Basic Investigation
  • Published:
Chinese Journal of Cancer Research

Abstract

The ability of human recombinant interleukin-6 (IL-6) to regulate the induction and cytotoxic function of lymphokine activated killer (LAK) cells from human fetal spleen was studied. The results showed that IL-6 alone was unably to induce fetal splenic mononuclear cells (FSMC) to develop functional LAK cells, nor was it able to affect the number of IL- 2- induced LAK cells and to alter the lytic activity of LAK cells against tumor cells in effector phase. However, when IL- 6 was used in combination with IL- 2 during the induction phase, the resulting LAK cells displayed considerably greater lytic, activity than that with IL-2 alone (P<0.01), and this effect was IL-6 dose-dependent. The possible machanism of the synergistic effect of IL-2 and IL-6 in LAK cell induction from human fetal spleen is discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. 1991; 13(2):145.

  2. Gallagher G, et al. IL-3 and IL-4 each strongly inhibit the induction and function of human LAK cells. Clin Exp Immunol 1988,74: 166.

    PubMed  CAS  Google Scholar 

  3. Ochoa AC, et al. Long-term growth of LAk cells: role of anti-CD3, IL-1β, IFN-γ and IFN-β. J Immunol 1987; 138: 2728.

    PubMed  CAS  Google Scholar 

  4. Ramsdell FJ, et al. Generation of LAk cell activity from human thymocytes. J Immunol 1987; 139,1446.

    PubMed  CAS  Google Scholar 

  5. Kishimoto T, et al. Multiple function of interleukin-6. Blood 1989,74,1.

    PubMed  CAS  Google Scholar 

  6. Chen L, et al. Growth inhibition of human breast carcinoma and leukemia/ lymphoma cell lines by recombinant IFN-β2. Proc Natl Acad Sci USA 1988; 85:8037.

    Article  PubMed  CAS  Google Scholar 

  7. Mule JJ, et al. Antitumor activity of recombinant interleukin- 6 in mice. J Exp Med 1990; 171,629.

    Article  PubMed  CAS  Google Scholar 

  8. Okada M, et al. IL-6/IFN-β2, function as a killer helper factor in the invitro induction of cytotoxic T cells. J Immunol 1988; 141: 1543.

    PubMed  CAS  Google Scholar 

  9. 6(5):280.

  10. Herberman RB, et al. LAK cell activity, characteristics of effector cells and their progenitor in blood and spleen. Immunol Today 1987; 8:178.

    Article  Google Scholar 

  11. Garman RD, et al. B-cell-stimulatory factor 2 (IFN-β2) function as a second singnal for IL-2 production by nature T cells. Proc Natl Acad Sci USA 1987; 84,7629.

    Article  PubMed  CAS  Google Scholar 

  12. 1991; 7(3):155.

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lu, L., Cui, Z., Zhang, L. et al. Experimental study on interleukin 6 activity against tumor; Regulation of interleukin-2 induced lak cell activity. Chin J Cancer Res 5, 263–267 (1993). https://doi.org/10.1007/BF03023757

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03023757

Key words

Navigation